Ozempic is a brand name for the drug Semaglutide produced and distributed by Novo Nordisk. It is used to treat type 2 diabetes. Ozempic belongs to the class of drugs known as GLP-1 receptor agonists, which mimic the effects of the natural hormone GLP-1 to regulate blood sugar levels. Ozempic is administered via injection, typically once a week. It helps manage blood glucose levels and has also been associated with weight loss in many patients.